Mechanisms of inflammasome activation and pyroptosis induction by HIV
Mechanisms of inflammasome activation and pyroptosis induction by HIV
批准号:
318292016
负责人:
Professor Dr. Eicke Latz
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2019-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The progressive loss of CD4 T cells during HIV progression in non-treated patients leads to the clinical syndrome AIDS. Activated CD4 T cells die through caspase-3 mediated apoptosis during HIV infection. However, the large majority of CD4 T cells (more than 95%) that die during HIV infection are quiescent lymphoid CD4 T cells. Recently, it has been discovered that these quiescent lymphoid CD4 T cells undergo caspase-1 mediated pyroptotic cell death rather than apoptosis after HIV infection. It is thought that aberrant nucleic acids are produced during the process of so-called abortive infection which are directly recognized by the nuclear nucleic acid sensor IFI16. IFI16, in turn, forms an active inflammasome together with the adapter protein ASC in a paranuclear area leading to auto-proteolytic activation of caspase-1. Active caspase-1 proteolytically activates members of the IL-1b cytokine family and mediates pyroptosis. Of note, peripheral quiescent CD4 T cells do not die from IFI16-mediated pyroptosis upon HIV infection, unless they receive signals from lymphoid quiescent CD4 T cells. The mechanisms underlying the cell type and activation dependent induction of the IFI16 inflammasome and subsequent pyroptotic cell death remain ill defined. We have performed extensive chemical biology screens in macrophages to better understand the mechanisms of inflammasome activation by other triggers. Our preliminary data show that many specific signaling pathways act to control inflammasome activation and influence the threshold of inflammasome responses to various triggers. In this proposal we aim to extend these studies and perform chemical biology screens in human lymphoid aggregate cultures (HLAC) infected with HIV to gain a better understanding of the mechanisms driving IFI16 inflammasome formation and pyroptosis induction. Through an integrated collaborative research plan we aim to identify and verify novel factors acting in HIV restriction in quiescent CD4 lymphoid CD4 T cells. We also aim to verify whether these newly uncovered pathways more generally regulate the formation of other inflammasomes and pyroptosis in other cell types.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of Innate Immune Responses against HIV with Camelid Nanobodies
-
批准号:429513120
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Professor Dr. Eicke Latz
-
依托单位:
Inflammasome activiation in Alzheimer´s disease
-
批准号:192135397
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Professor Dr. Eicke Latz
-
依托单位:
国内基金
海外基金
登录
查看更多内容
视网膜色素上皮细胞中YAP/mtDNA/cGAS-炎症小体轴在干性年龄相关性黄斑变性中的作用
-
批准号:82371073
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄珮戎
-
依托单位:
自噬流/炎症小体失衡在新生儿缺血缺氧性脑病中的作用机制
-
批准号:82372205
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:崔德荣
-
依托单位:
LTB4/BLT1轴调控NLRP3炎症小体对糖尿病认知功能障碍的作用研究
-
批准号:82371213
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:王修哲
-
依托单位:
mt DNA/AIM2 inflammasome/ neuronal pyroptosis途径参与创伤性颅脑损伤后认知功能障碍发生的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:盛江涛
-
依托单位:
TRPV1通过CaMKII-AMPK/NLRP3通路调控巨噬细胞破骨化在腹主动脉瘤中的作用机制研究
-
批准号:82100502
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李雪灵
-
依托单位:
急性肺损伤中AQP3在NLRP3炎症小体介导的肺巨噬细胞焦亡中的作用
-
批准号:32060158
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:阿不都许库尔·阿不力米提
-
依托单位:
NLRP3-inflammasome介导的细胞焦亡在脑出血神经元继发性损伤的作用和机制研究
-
批准号:81901220
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:初翔
-
依托单位:
AngII—NLRP3 Inflammasome 信号通路在湿热应激心脏损伤中的作用机制研究
-
批准号:81671885
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2016
-
负责人:王晓武
-
依托单位:
小胶质细胞焦亡及其NLRP/inflammasome/caspase-1调控通路在脑出血中的作用机制
-
批准号:81571108
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:张相彤
-
依托单位:
腺泡细胞焦亡及其HIF/Inflammasome/Caspase-1调控通路在急性胰腺炎中的作用及机制研究
-
批准号:81470887
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:白雪巍
-
依托单位: